Evidence map›Paper›PMID 11427558›Full record

ArticleJournal of clinical microbiology2001

Serological expression cloning and immunological evaluation of MTB48, a novel Mycobacterium tuberculosis antigen.

M J Lodes, D C Dillon, R Mohamath, C H Day, D R Benson, L D Reynolds, P McNeill, D P Sampaio, Y A Skeiky, R Badaro and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Antibodies as clinical tools for tuberculosis.Frontiers in immunology · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Use of multiepitope polyproteins in serodiagnosis of active tuberculosis.Clinical and diagnostic laboratory immunology · 2002
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

M J LodesCorixa Corporation, Seattle, Washington 98104, USA. lodes@corixa.com
D C Dillon
R Mohamath
C H Day
D R Benson
L D Reynolds
P McNeill
D P Sampaio
Y A Skeiky
R Badaro
D H Persing
S G Reed
R L Houghton
Corixa Corporation · USUniversidade Federal da Bahia · BRUniversity of Washington · US

Funding

HUMAN T CELLS ANTIGENS OF MYCOBACTERIUM TUBERCULOSISR01AI044373 · NIAID · INFECTIOUS DISEASE RESEARCH INSTITUTE · PI REED, STEVEN GREGORY · 1999 to 2009
$3.7M
TUBERCULOSIS RESEARCH MATERIALSN01AI025147 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI BRENNAN, PATRICK JOSEPH · 1992 to 1997
–
NOVEL ANTIGENS FOR USE IN SERODIAGNOSIS OF TUBERCULOSISR43AI039879 · NIAID · CORIXA CORPORATION · PI HOUGHTON, RAYMOND · 1996 to 1996
–
NOVEL ANTIGENS FOR USE IN SERODIAGNOSIS OF TUBERCULOSISR44AI039879 · NIAID · CORIXA CORPORATION · PI HOUGHTON, RAYMOND · 1997 to 1998
–
NIAID NIH HHS AI-39879NIAID NIH HHS AI-44373NIAID NIH HHS N01-AI-25147NIAID NIH HHS R01 AI044373
6 · The paper itself

Abstract

Improved diagnostics are needed for the detection of Mycobacterium tuberculosis, especially for patients with smear-negative disease. To address this problem, we have screened M. tuberculosis (H37Rv and Erdman strains) genomic expression libraries with pooled sera from patients with extrapulmonary disease and with sera from patients with elevated reactivity with M. tuberculosis lysate. Both serum pools were reactive with clones expressing a recombinant protein referred to here as MTB48. The genomic sequence of the resulting clones was identical to that of the M. tuberculosis H37Rv isolate and showed 99% identity to the Mycobacterium bovis and M. bovis BCG isolate sequences. The genomic location of this sequence is 826 bp upstream of a region containing the esat-6 gene that is deleted in the M. bovis BCG isolate. The mtb48 1,380-bp open reading frame encodes a predicted 47.6-kDa polypeptide with no known function. Southern and Western blot analyses indicate that this sequence is present in a single copy and is conserved in the M. tuberculosis and M. bovis isolates tested but not in other mycobacterial species tested, including Mycobacterium leprae and Mycobacterium avium. In addition, the native protein was detected in the cytoplasm, as was a processed form that was also shed into the medium during culture. Serological analysis of recombinant MTB48 and the M. tuberculosis 38-kDa antigen with a panel of patient and control sera indicates that the inclusion of recombinant MTB48 in a prototype serodiagnostic test increases assay sensitivity for M. tuberculosis infection when it is combined with other known immunodominant antigens, such as the 38-kDa antigen.

Indexed as

Antigens, BacterialBacterial ProteinsAmino Acid SequenceAnimalsBase SequenceBlotting, SouthernBlotting, WesternCloning, MolecularEnzyme-Linked Immunosorbent AssayHumansMolecular Sequence DataMycobacterium tuberculosisRabbitsRecombinant ProteinsSequence Analysis, DNATuberculosis, PulmonaryAntigens, BacterialBacterial ProteinsMTB48 protein, Mycobacterium tuberculosisRecombinant Proteins

Identifiers

PMID11427558
PMCPMC88174
OpenAlexW2097122890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.